The relationship between sperm viability and DNA fragmentation rates by Mary K Samplaski et al.
Samplaski et al. Reproductive Biology and Endocrinology  (2015) 13:42 
DOI 10.1186/s12958-015-0035-yRESEARCH Open AccessThe relationship between sperm viability and
DNA fragmentation rates
Mary K Samplaski1, Apostolos Dimitromanolakis2, Kirk C Lo1,3, Ethan D Grober1, Brendan Mullen2, Alaina Garbens1
and Keith A Jarvi1,3,4*Abstract
Background: In humans, sperm DNA fragmentation rates have been correlated with sperm viability rates. Reduced
sperm viability is associated with high sperm DNA fragmentation, while conversely high sperm viability is associated
with low rates of sperm DNA fragmentation. Both elevated DNA fragmentation rates and poor viability are correlated
with impaired male fertility, with a DNA fragmentation rate of > 30% indicating subfertility. We postulated that in some
men, the sperm viability assay could predict the sperm DNA fragmentation rates. This in turn could reduce the
need for sperm DNA fragmentation assay testing, simplifying the infertility investigation and saving money for
infertile couples.
Methods: All men having semen analyses with both viability and DNA fragmentation testing were identified via a
prospectively collected database. Viability was measured by eosin-nigrosin assay. DNA fragmentation was measured
using the sperm chromosome structure assay. The relationship between DNA fragmentation and viability was assessed
using Pearson’s correlation coefficient.
Results: From 2008-2013, 3049 semen analyses had both viability and DNA fragmentation testing. A strong inverse
relationship was seen between sperm viability and DNA fragmentation rates, with r = -0.83. If viability was≤ 50%
(n = 301) then DNA fragmentation was≥ 30% for 95% of the samples. If viability was≥ 75% (n = 1736), then the DNA
fragmentation was≤ 30% for 95% of the patients. Sperm viability correlates strongly with DNA fragmentation rates.
Conclusions: In men with high levels of sperm viability≥ 75%, or low levels of sperm viability≤ 30%, DFI testing may
be not be routinely necessary. Given that DNA fragmentation testing is substantially more expensive than vitality
testing, this may represent a valuable cost-saving measure for couples undergoing a fertility evaluation.
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Both elevated DNA fragmentation and poor viability are
known to be associated with male factor infertility.
These two conditions are linked, as DNA fragmentation
is one of the final steps before spermatozoa death [1]
and conversely, DNA breaks are one of the primary in-
stigators of sperm apoptosis [2-4]. The literature has
demonstrated a clear link between DNA fragmentation
and sperm viability [5], and in groups of men with high
levels of DNA fragmentation, high levels of necrosper-
mia are also seen [5].* Correspondence: kjarvi@mtsinai.on.ca
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unless otherwise stated.The “Georgetown Male Factor Infertility Study” was the
first study to establish DNA fragmentation fertility data in
humans [6]. Data from this study were used to establish
the thresholds DNA fragmentation and fertility data. For
male fertility, the sperm chromatin structure assay was
used to define > 30% DNA fragmentation as “significant
lack of”, 15-30% DNA fragmentation as ‘reasonable’
and < 15% DNA fragmentation for ‘high’ fertility status [6].
Subsequent studies have also demonstrated that a sperm
DNA fragmentation rate of > 30% is correlated with im-
paired fertility outcomes. A meta-analysis of four studies,
with a total of 1962 men evaluating the relationship bet-
ween sperm DNA fragmentation and spontaneous and
intrauterine insemination pregnancies found that menral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Semen analysis DNA fragmentation rates when
grouped by viability
Sperm viability DNA fragmentation rate
(mean +/- standard deviation)
0-20% 70.07 +/- 34.39%
21-40% 58.03 +/- 28.28%
41-60% 38.19 +/- 17.95%
61-80% 20.40 +/- 10.16%
81-100% 12.40 +/- 5.61%
Higher sperm DNA fragmentation rates were associated with lower sperm
viability rates.
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achieve a pregnancy or live birth (p = 0.0001) [6-8]. The
second study looked at the relationship between DNA
fragmentation and in vitro fertilization pregnancies, and
found that couples were ~2x more likely to become preg-
nant if the sperm DNA fragmentation rate was < 30%
[7,9]. These studies and others, support the notion that
semen samples with ≥ 30% sperm DNA fragmentation by
sperm chromatin structure assay have reduced fertility [10].
Necrospermia is defined as the percentage of dead
sperm in a semen analysis sample > 42%, and is usually
measured by assessing the membrane integrity of the
cells, as determined by a dye exclusion assay [11,12]. In
spite of its relatively straightforward definition, the cau-
ses and impact of necrospermia on male fertility are still
relatively poorly understood. Necrospermia is commonly
seen in men with spinal cord injuries [12], infections
[13], chronic medical conditions [5], and after exposure
to toxic substances [14]. While intuitively it makes sense
that high levels of necrospermia are associated with
poorer reproductive outcomes, there is a paucity of lite-
rature to support this.
One of the primary disadvantages of DNA fragmenta-
tion testing is its cost. Compared with other male fer-
tility testing, DNA fragmentation testing is costly, as
vitality testing costs approximately $2 and DNA frag-
mentation testing costs approximately $250, based on
internal and internet quotes [15]. These costs generally
are transferred to the patient and can add further finan-
cial burden to a couple looking to conceive.
We sought to determine the relationship between
sperm viability and DNA fragmentation, with the hy-
pothesis that for some patients, sperm DNA fragmenta-
tion rates could be predicted from the sperm viability
rates. This may eliminate the need for sperm DNA frag-
mentation testing in a subset of men, representing a
cost-saving measure for some couples undergoing a fer-
tility evaluation.
Methods
All men presenting for a fertility evaluation from 2008-
2013, and having semen analyses with both viability and
DNA fragmentation testing were identified. This data
was reviewed in a retrospective manner. The collection of
data and the analysis of the data in this database were ap-
proved by the Research Ethics Board of the Mount Sinai
Hospital with reference number 05-0161-E (collection of
data) and 07-0032-E (analysis of data) respectively. The
date of the approval was October 18, 2005 and October
30, 2007. All participants have signed the IRB approved
informed consent form.
Semen samples were collected at Mount Sinai Hospital,
at least 48 hours, but not more than 7 days, after the time
of last ejaculation. Semen samples were collected between2 and 5 days from the last ejaculation. Semen samples
were assessed for volume and then analyzed for sperm
count, sperm concentration and motility following the
2001 WHO criteria. These criteria are based on micro-
scopic high-power evaluation of 200 sperm for intactness
of membranes of acrosome, head, neck, midpiece and tail.
Viability was assessed within 30 minutes of ejaculation.
It was measured by eosin-nigrosin assay, by dissolving
1 g of eosin with 1 g of fresh sperm and then 3 g of
nigrosin [16]. The percentage of viable sperm (sperm
head unstained indicating living sperm) and non-viable
sperm (sperm head stained indicating dead spermatozoa)
was assessed by counting a minimum of 100 spermato-
zoa. Replicate counts of 100 sperm on each of two slides
were performed. These were then repeated if >5% diffe-
rence was found.
DNA fragmentation testing was performed on a frozen
prepared semen sample using the sperm chromosome
structure assay, as previously described [17]. Samples were
treated for 30 seconds with 400 μL of a solution of 0.1%
Triton X-100, 0.15 M NaCl, and 0.08 N HCl (pH 1.2).
After 30 seconds, 1.2 mL of staining buffer (6 μg/mL ac-
ridine orange, 37 mM citric acid, 126 mM Na2HPO4,
1 mM disodium EDTA, and 0.15 M NaCl, pH 6.0) was
admixed to the test tube, and the sample was analyzed by
flow cytometry. After excitation by a 488-nm wavelength
light source, acridine orange bound to double-stranded
DNA fluoresced green (515 to 530 nm) and acridine
orange bound to single-stranded DNA fluoresced red
(630 nm or more). Three minutes after acridine orange
staining, samples were analyzed in a flow cytometry acti-
vated cell sorter (Caliburflow cytometer, Becton Dickinson,
San Jose, California). A minimum of 5000 cells were
analyzed by a flow cytometry activated cell sorter scan
interfaced with a data handler. The proportion of cells
exhibiting an abnormal emission of red fluorescence, re-
flecting the percentage of sperm with denatured DNA,
was recorded.
The relationship between DNA fragmentation and via-
bility was assessed using Pearson’s product moment cor-
relation coefficient. P-values and confidence intervals were
obtained by standard methods, assuming normality of the
Figure 1 Sperm DNA fragmentation versus necrospermia. A strong inverse relationship (p < 0.001) was seen between viability and DNA fragmentation. If
viability was≥ 75%, then the DNA fragmentation was < 30% for 95% of the patients. If viability was≤ 50% then DNA fragmentation was≥ 30% for 95%
of the samples.
Table 2 Number of men having viability testing with DNA
fragmentation ≥ or < 30% (95% confidence interval)
Viability DNA fragmentation rate
(95% confidence interval)
Number of men (%)
≥ 75% < 30% 1736 (56.9%)
74-49% 1004 (32.9%)
≤ 50% ≥ 30% 310 (10.2%)
If sperm viability was ≥ 75% (n = 1736), then the DNA fragmentation was < 30%
for 95% of the patients. If sperm viability was ≤ 50% then DNA fragmentation
was ≥ 30% for 95% of the samples (n = 310).
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for Statistical Computing, version 2.15.2.
Results
A total of 2695 men underwent semen analysis testing
with both DNA fragmentation and viability assays. Some
men had multiple semen analyses with DNA fragmenta-
tion and viability testing. 2438 men had 1 test, 191 men
had 2 tests, 37 men had 3 tests, 15 men had 4 tests, 3
men had 5 tests, 6 men had 6 tests, and 1 man had 7
tests. A total of 3049 semen samples with both DNA
fragmentation and viability testing were performed.
Of the 3049 semen samples analyzed, 47 (1.5%) had
sperm viability of 0-20%, 113 (3.7%) had viability of 21-40%,
450 (14.8%) had viability of 41-60%, 1920 (63%) had via-
bility of 61-80%, and 519 (17%) had viability of 81-100%.
Higher sperm DNA fragmentation rates were associated
with lower sperm viability rates (see Table 1), and samples
with the lowest sperm viability 0-20% had the highest
sperm DNA fragmentation rates (70.07 ± 34.39%), and
samples with the highest sperm viability rates, 81-100%,
were associated with the lowest sperm DNA fragmenta-
tion rates (12.40 ± 5.61%).
433 (16.1%) samples had a sperm viability of ≤ 58%,
the lower limit of normal according to the 2010 WHO
laboratory manual guidelines [18]. For these samples,
the mean DNA fragmentation was 48.65 ± 25.59%. For
the 2262 samples with viability > 58%, the mean DNA
fragmentation was 19.57 ± 10.58% (p < 0.001).
A strong inverse relationship (p < 0.001) was seen
between sperm viability and DNA fragmentation, with
Pearson’s product-moment correlation coefficient r = -0.83
(Figure 1), t = -80.69, df = 3047, p < 0.001 and a 95% confi-
dence interval of -0.836 to -0.814. If viability was very high(≥ 80%, n = 1104) then DNA fragmentation was consis-
tently < 30% (100% sensitivity to predict DNA fragmenta-
tion < 30%). If viability was≥ 75% (n = 1736), then the DNA
fragmentation was < 30% for 95% of the patients (Table 2).
For samples with very low viability (viability ≤ 35%, n = 91)
then DFI was always ≥ 30%. If viability was ≤ 50% then
DNA fragmentation was ≥ 30% for 95% of the samples
(n = 310). The results of the semen analysis testing with
respect to vitality and DFI are seen in Tables 3 and 4.
Discussion
Both elevated sperm DNA fragmentation and poor
sperm viability are linked to male infertility. While it is
unclear in some cases which process comes first, the
two are linked and the literature has demonstrated a
clear link between DNA fragmentation and sperm via-
bility [5]. Both apoptosis and necrosis result in DNA
fragmentation, either by an active mechanism through
apoptotic endonuclease activation or passively as in ne-
crosis [19,20]. DNA fragmentation may also be seen in
mature, viable sperm, although the mechanisms that
trigger this degradation have not been fully elucidated
[21,19]. After ejaculation, the incidence of sperm DNA
Table 3 Semen analysis parameters as grouped by viability
Viability Ejaculate volume Concentration Motility Normal morphology Total motile sperm count
≥ 75% 2.82 +/- 1.49 mL 64.23 +/- 56.05 31.89 +/- 12.62% 20.93 +/- 11.34% 58.15 +/- 61.38
74-49% 3.00 +/- 1.72 mL 54.55 +/- 58.81 22.88 +/- 11.45% 16.27 +/- 10.89% 37.44 +/- 51.82
≤ 50% 2.55 +/- 1.79 mL 38.74 +/- 44.57 8.23 +/- 7.12% 12.04 +/- 9.34% 10.31 +/- 17.88
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lation [19,22] and with temperatures of 37°C or greater
[23,24], but there is great inter-individual variability in
these increases [19].
While reported correlations between DNA fragmenta-
tion and sperm concentration in subfertile men have
varied [25-27], the literature has demonstrated a clear
link between sperm DNA fragmentation and sperm via-
bility [5]. For groups of men with high levels of sperm
DNA fragmentation, high levels of necrospermia are also
seen [5]. In addition, increases in DNA fragmentation
rates following incubation of human spermatozoa have
been shown to correlate strongly with sperm viability
loss [28].
Elevated sperm DNA fragmentation rates have been
positively correlated with impaired fertility, including
longer times to natural conception [8], impaired embryo
cleavage [29], impaired implantation rates [30], higher
miscarriage rates [29], and increased risk of pregnancy
loss after both in vitro fertilization and intracytoplasmic
sperm injection [31]. Using the sperm chromosome
structure assay, couples with a sperm DNA fragmenta-
tion of < 40% have been shown to have an odds ratio of
10× greater probability of pregnancy via natural inter-
course than those with DNA fragmentation > 40% [8].
Likewise, intrauterine insemination patients have been
shown to be 8.7× more likely to have a live birth if the
DNA fragmentation is ≤ 27% [7]. Finally, a DNA frag-
mentation rate of ≥ 30% has been associated with in-
creased spontaneous abortion rates [32]. In addition to
these individual studies, two large meta-analyses using
the sperm chromatin structure assay have demonstrated
the clear relationship between DNA fragmentation and
pregnancy. The first of these was a meta-analysis of four
studies, with a total of 1962 men, found that men with a
DNA fragmentation < 30% were more likely to achieve a
pregnancy or live birth either spontaneously or via in-
trauterine insemination (p = 0.0001) [6-8]. The second
found that couples were ~2× more likely to becomeTable 4 Semen analysis parameters as grouped by DNA fragm
DNA fragmentation Ejaculate volume Concentration Mot
< 30% 2.84 +/- 1.53 mL 62.06 +/- 56.23 30.36
≥ 30% 2.93 +/- 1.84 mL 49.38 +/- 57.05 16.5pregnant via in vitro fertilization if their DNA fragmen-
tation was < 30% [7,9]. Because of studies like this, sperm
DNA fragmentation testing has been used increasingly
as an adjunct to the standard sperm parameters [33-35].
Interestingly, while a DNA fragmentation cutoff of 30%
is commonly used, there are limited studies looking at
DNA fragmentation rates > 30%. We identified a single
study which compared reproductive outcomes in men
with sperm having DNA fragmentation rates of ≤15%
compared with > 50% [33]. They found that using sperm
selected by movement and morphology characteristic for
intracytoplasmic sperm injection, couples with high sperm
DNA fragmentation rates had similar fertilization and
clinical pregnancy rates compared with sperm with low
DNA fragmentation rates [33]. There are otherwise no
studies looking at sperm DNA fragmentation rates > 30%,
but the literature clearly demonstrates that a DNA frag-
mentation of > 30% negatively correlates with male repro-
ductive outcomes.
Necrospermia is defined as a high percentage of dead
sperm, as determined in our study by dye exclusion
[11,12]. Living sperm have an intact cytoplasmic mem-
brane, which is the basis for viability assays such as or
dye exclusion testing, which tests sperms’ ability to resist
the absorption of certain dyes, including eosin, nigrosin,
or trypan blue [16]. According to the 2010 WHO labo-
ratory manual for the examination and processing of
human semen, the lower reference limit for viability
(membrane-intact spermatozoa) is 58% (5th centile, 95%
CI 55–63) [18].
The incidence of necrospermia in the fertile and infer-
tile populations is poorly defined. A 2003 study of 4108
infertile men identified a prevalence of 0.7% [36], and
a 2004 study estimated the prevalence of epididymal
necrospermia at 0.5% in healthy men undergoing infer-
tility work-up [37]. Both of these studies used a viability
of 40% dead sperm as their cutoff definition of necros-
permia, whereas we used the WHO 2010 guidelines
which state that 42% dead sperm is the cutoff forentation
ility Normal morphology Total motile sperm count
+/- 12.74% 20.06 +/- 11.31% 56.67 +/- 10.96
+/- 11.3% 14.2 +/- 10.71% 26.21 +/- 43.44
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dence of necrospermia of 16.1% in our population of in-
fertile males, relatively high compared with the prior
reported rates. For these samples, the mean DNA frag-
mentation was 48.65 ± 25.59%. For the 2262 samples
with viability > 58%, the mean DNA fragmentation was
19.57 ± 10.58% (p < 0.001). Thus our data clearly support
the notion that men with WHO defined necrospermia
have higher rates of DNA fragmentation. However, in
spite of its relatively straightforward definition and diag-
nosis, the impact and etiology of necrospermia in men
with infertility is still relatively poorly understood.
This is the first study to use vitality as a predictor for
the level of sperm DNA fragmentation. Given our fin-
dings, in men with sperm vitality of ≥ 75%, routine DNA
fragmentation testing is unlikely to provide any addi-
tional information, as in these men sperm DNA frag-
mentation is very likely to be low. Likewise, for men
with sperm vitality of ≤ 50% routine DNA fragmentation
testing may not be required as > 95% will have sperm
DNA integrity of > 30%. Based on these estimates, only
32.9% of men in our series undergoing both viability and
DNA fragmentation testing would have gained addi-
tional information from DNA fragmentation testing
(Table 2). In the majority of men, viability testing may
predict sperm DNA fragmentation rates, allowing the
couple to avoid the sperm DNA fragmentation assay and
may represent a valuable cost-saving measure. While a for-
mal cost-analysis was not performed, this may represent a
valuable cost-savings measure for couples undergoing fer-
tility evaluation, as viability testing costs approximately $2
and DNA fragmentation testing costs approximately $250,
based on internal and internet quotes [15].
Conclusions
Sperm viability correlates strongly with DNA fragmenta-
tion rates and is predictive of sperm DNA fragmentation
rates. In men with high levels of sperm viability ≥ 75%, or
low levels of sperm viability ≤ 30%, DFI testing may not
provide additional information. Given that DNA fragmen-
tation testing is approximately 100× more expensive than
viability testing ($250 versus $2), this may represent a
valuable cost-saving measure for couples undergoing a fer-
tility evaluation.
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